Showing results (921-930 of 1,030) with videos related to
Sort By:
Pageof 103
European Journal of Cancer (Oxford, England : 1990)|June 10, 2018
Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trialM G M Derks, E Bastiaannet, W van de Water, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2013
Anticancer effects of niclosamide in human glioblastomaAnja Wieland, Daniel Trageser, Sabine Gogolok, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Gene expression signature to improve prognosis prediction of stage II and III colorectal cancerRamon Salazar, Paul Roepman, Gabriel Capella, et al.BMJ (Clinical Research Ed.)|September 17, 2014
Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based studyNienke A de Glas, Anton J M de Craen, Esther Bastiaannet, et al.Clinical Nuclear Medicine|April 16, 2019
Comparison of L-Methyl-11C-Methionine PET With Magnetic Resonance Spectroscopy in Detecting Newly Diagnosed GliomaSied Kebir, Lazaros Lazaridis, Manuel Weber, et al.International Journal of Methods in Psychiatric Research|November 14, 2012
The Netherlands Obsessive Compulsive Disorder Association (NOCDA) study: design and rationale of a longitudinal naturalistic study of the course of OCD and clinical characteristics of the sample at baselineJosien Schuurmans, Anton J L M van Balkom, Harold J G M van Megen, et al.Journal of Virology|June 13, 2024
Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteriaShannon C David, Aline Schaub, Céline Terrettaz, et al.Acta Neuropathologica|January 9, 2016
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entityUlrich Herrlinger, David T W Jones, Martin Glas, et al.NPJ Breast Cancer|September 27, 2017
DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trialDenise M Wolf, Christina Yau, Ashish Sanil, et al.Breast Cancer Research : BCR|August 31, 2017
The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant settingTesa M Severson, Denise M Wolf, Christina Yau, et al.Pageof 103